Issue |
Section |
Title |
File |
Vol 16, No 4 (2017) |
Статьи |
Blinatumomab therapy for relapsed and refractory acute lymphoblastic leukemia |
 (Rus)
|
Vol 16, No 3 (2017) |
Статьи |
The results of pilot trial ALL-REZ-MВ-2014 for children with relapsed acute lymphoblastic leukemia |
 (Rus)
|
Vol 14, No 2 (2015) |
ЛИМФОМЫ |
Brentuximab vedotin in therapy of a patient with refractory Hodgkin’s lymphoma and Proteus syndrome |
 (Rus)
|
Vol 14, No 2 (2015) |
ЛИМФОМЫ |
Cerebral venous sinus thrombosis and bleeding in the brain in a patient with lymphoblastic lymphoma |
 (Rus)
|
Vol 18, No 1 (2019) |
PROMISING STUDIES |
First results of pilot protocol ALl-REZ-2016 for children with high risk groups of relapsed acute lymphoblastic leukemia |
 (Rus)
|
Vol 18, No 1 (2019) |
ORIGINAL ARTICLES |
Efficacy and toxicity of the treatment of children and adolescents with Hodgkin Lymphoma by GPOH-HD-2002 protocol |
 (Rus)
|
Vol 20, No 3 (2021) |
ORIGINAL ARTICLES |
Incidence of venous thromboembolism in children with primary lymphomas |
 (Rus)
|
Vol 22, No 1 (2023) |
ORIGINAL ARTICLES |
Treatment of lymphoid malignancies in patients with primary immunodeficiencies associated with DNA repair defects |
 (Rus)
|
Vol 22, No 1 (2023) |
ORIGINAL ARTICLES |
The evaluation of minimal disseminated disease in the bone marrow of children with Burkitt lymphoma using next generation sequencing |
 (Rus)
|
Vol 22, No 1 (2023) |
ORIGINAL ARTICLES |
The use of inotuzumab ozogamicin in children with relapsed/refractory B-lineage acute lymphoblastic leukemia |
 (Rus)
|
Vol 22, No 1 (2023) |
ORIGINAL ARTICLES |
The role of blinatumomab in the treatment of B-cell relapses of acute lymphoblastic leukemia in children: own experience |
 (Rus)
|
Vol 23, No 1 (2024) |
ORIGINAL ARTICLES |
The prognostic value of TP53 mutational status in children with Burkitt lymphoma treated according to the B-NHL-2010M protocol |
 (Rus)
|